AITRICS

AITRICS, founded in 2016 and headquartered in Korea South, aims to revolutionize the healthcare industry with its artificial intelligence-based medical services. The company's flagship product, AITRICS-VC, utilizes world-class AI technology to provide real-time patient monitoring and early-stage emergency prediction, ultimately saving lives and enhancing workflow efficiency for medical staff.

With a focus on risk prevention and clinical problem-solving, AITRICS is at the forefront of leveraging AI to identify potential causes of medical emergencies before they occur. The recent KRW27.10B Series B investment on 21 March 2024, led by Premier Partners, HB Investment, BSK Investment, BNH Investment, DS Investment & Securities, Shinyoung Securities, Ulmus Investment, HRZ, and Bonum Investment, underscores the confidence of investors in AITRICS' exceptional technology and its potential to significantly impact the healthcare and information technology industries.

AITRICS' commitment to providing high-quality medical care beyond existing limits positions the company as a compelling investment opportunity in the rapidly evolving healthcare analytics and technology landscape.